- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06419556
Analgesic Efficacy of an Intermediate CPB in Neck Surgeries.
Analgesic Efficacy of an Intermediate Cervical Plexus Block in Patients Undergoing Neck Surgeries. A Comparison Between Two Bupivacaine Concentrations.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This randomized comparative study was conducted in Cairo University hospitals after the approval of the institutional research and ethics committee. Informed consent was obtained from all participants. The Consolidated Standards of Reporting Trials (CONSORT) Guidelines were followed.
The patients were randomly allocated into two groups (H & L) using computer generated random numbers that were concealed in opaque envelopes. Group H received 20 ml 0.25 % bupivacaine and Group L received 20 ml 0.125% bupivacaine bilaterally.
- On arrival to the operating room, an 18G cannula was inserted with the infusion of 500 ml Ringer solution. Controloc 40 mg, ondansetron 8 mg, and dexamethasone 8 mg were administered as premedication. The diaphragmatic motion was assessed by a 3.5 MHz curvilinear transducer, siemens ACUSON X300 ultrasound. Each hemidiaphragm was first visualized by B-mode then M-mode was used to evaluate diaphragmatic excursion. For the right hemidiaphragm, the transducer was placed perpendicularly over the right subcostal margin in the anterior axillary line, the prob was then directed cephalad and dorsally to reach the posterior one-third of the diaphragm. Diaphragmatic excursions were measured and recorded in millimeters using the liver as an acoustic window during quiet breathing. The left hemidiaphragm was assessed in the same way using the spleen as an acoustic window.
- All patients connected to an electrocardiograph (ECG), pulse oximeter, and non-invasive blood pressure (NIBP), and baseline values of HR and MAP were measured and recorded. Additional monitoring in the form of a capnogram, invasive blood pressure (IBP) through a radial artery cannula, peripheral nerve stimulator (PNS), Bispectral index (BIS), and urine output were connected after induction of GA. Anesthesia was induced by intravenous fentanyl 2µg/kg, propofol 1.5-2 mg/kg, and atracurium 0.5 mg. When the TOF count showed the disappearance of T1 (0/4), an appropriate-size endotracheal tube was inserted and secured. Under complete aseptic conditions, ultrasound guided bilateral ICPB was performed by a single staff anesthetist who is skilled in carrying out regional anesthesia.
- ICPB technique: The patient's head was rested on a pillow and turned to the opposite side. A linear probe with higher frequencies was placed transversely over the midpoint of the SCM muscle. The carotid artery was identified and traced upwards to its bifurcation. the probe was then moved laterally to identify the tapering posterolateral end of the SCM muscle. Via an in-plane technique, a 22-gauge, 50 mm needle was advanced underneath the investing fascia of SCM muscle and above the interscalene groove until the "pop" on piercing the investing fascia was felt. The patient was then randomly allocated into two groups (H & L) using computer generated random numbers that were concealed in opaque envelopes. Group H received 20 ml 0.25 % bupivacaine and Group L received 20 ml 0.125% bupivacaine. The technique was repeated on the opposite side.
- During the intraoperative period, anesthesia was maintained with isoflurane 1.2-1.5 vol% to keep BIS value at 40-60 and atracurium 0.1mg/kg guided by PNS. Additional doses of fentanyl 0.05 µg/kg were administered when HR or MAP increased > 20% of the baseline values. MAP and HR were measured after the skin incision, and then every 30 minutes till the end of surgery. The failed block was considered when ≥ four additional doses of fentanyl were required to manage the increased MAP or HR after skin incision. At the end of the surgery, one gram of paracetamol plus 30 mg of ketorolac were administered.
- During the postoperative period, regular analgesia in the form of intravenous paracetamol one gram/8hr was prescribed. Pain severity was assessed by using the visual analog scale (VAS) (0= no pain and 100mm= worst pain) at 2, 4, 6, 8, 12, 18, and 24 hr postoperatively. Rescue analgesia in the form of intravenous morphine 0.05 mg/kg was given on the patient's complaint or when VAS ≥ 40 mm and repeated every 15-20 minutes until VAS < 40 mm with a maximum morphine dose of 40 mg per 24 hours. The duration of analgesia was calculated as the time elapsed from the end of the ICPB block procedure till VAS ≥ 40mm. The total postoperative morphine consumption over 24 hours was calculated. The measurement of diaphragmatic excursions was repeated as mentioned above, hemi-diaphragmatic paresis was divided into three grades, depending on the percentage of diaphragm movement compared with baseline to be: none (> 75%), partial paresis (25-75%), and complete paresis (< 25%)
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nagy malak
- Phone Number: 01552480258
- Email: nagymalak12345@gmail.com
Study Contact Backup
- Name: Nagy malak
- Phone Number: 01552480258
- Email: nagymalak@kasralainy.edu.eg
Study Locations
-
-
Governorate
-
Cairo, Governorate, Egypt, 002
- Recruiting
- Cairo university Hospitals. kasralainy
-
Contact:
- Nagy malak
- Phone Number: 01552480258
- Email: nagymalak@kasralainy.edu.eg.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Any patient aged ≥ 40 years
- ASA physical status I-III scheduled for total thyroidectomy or total laryngectomy under GA.
Exclusion Criteria:
- Patients with heart failure
- history of arrhythmias
- treatment with antiarrhythmic drugs
- impaired pulmonary
- Liver or kidney functions
- Neck infection or rash
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group H
The patient's head was rested on a pillow and turned to the opposite side.
A linear probe with higher frequencies was placed transversely over the midpoint of the SCM muscle.
The carotid artery was identified and traced upwards to its bifurcation.
Probe was then moved laterally to identify the tapering posterolateral end of the SCM muscle.
Via an in-plane technique, a 22-gauge, 50 mm needle was advanced underneath the investing fascia of SCM muscle and above the interscalene groove until the "pop" on piercing the investing fascia was felt.
Group H received 20 ml 0.25 % bupivacaine
|
The patient's head was rested on a pillow and turned to the opposite side.
A linear probe with higher frequencies was placed transversely over the midpoint of the SCM muscle.
The carotid artery was identified and traced upwards to its bifurcation.
the probe was then moved laterally to identify the tapering posterolateral end of the SCM muscle.
Via an in-plane technique, a 22-gauge, 50 mm needle was advanced underneath the investing fascia of SCM muscle and above the interscalene groove until the "pop" on piercing the investing fascia was felt.
|
Active Comparator: Group L received 20 ml 0.125% bupivacaine
The patient's head was rested on a pillow and turned to the opposite side.
A linear probe with higher frequencies was placed transversely over the midpoint of the SCM muscle.
The carotid artery was identified and traced upwards to its bifurcation.
Probe was then moved laterally to identify the tapering posterolateral end of the SCM muscle.
Via an in-plane technique, a 22-gauge, 50 mm needle was advanced underneath the investing fascia of SCM muscle and above the interscalene groove until the "pop" on piercing the investing fascia was felt.
Group L received 20 ml 0.125% bupivacaine.
|
The patient's head was rested on a pillow and turned to the opposite side.
A linear probe with higher frequencies was placed transversely over the midpoint of the SCM muscle.
The carotid artery was identified and traced upwards to its bifurcation.
the probe was then moved laterally to identify the tapering posterolateral end of the SCM muscle.
Via an in-plane technique, a 22-gauge, 50 mm needle was advanced underneath the investing fascia of SCM muscle and above the interscalene groove until the "pop" on piercing the investing fascia was felt.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of analgesia
Time Frame: duration of operation up to 6 hours
|
duration of anesthesia and Block-skin incision time differ between two groups (two concentrations of bupivacaine)
|
duration of operation up to 6 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The diaphragmatic motions measured by M-mode ultrasonography
Time Frame: duration of operation up to 6 hours
|
Measured at two-time points: before anesthesia (baseline) and on arrival to PACU, with the calculation of the hemi-diaphragmatic paresis depending on the percentage of diaphragm movement compared with baseline as follows: none (> 75%), partial paresis (25-75%), and complete paresis (< 25%).
|
duration of operation up to 6 hours
|
Total postoperative Morphine consumption.
Time Frame: 24 hours
|
Total postoperative Morphine consumption.
|
24 hours
|
The postoperative VAS score
Time Frame: 24 hours
|
scale (0= no pain and 100 mm= worst pain) and measured at 2, 4, 6, 8, 12, 18, and 24 hr postoperatively.
Rescue analgesia in the form of intravenous morphine 0.05 mg/kg given on the patient's complaint or when VAS ≥ 40 mm and repeated every 15-20 minutes until VAS < 40 mm with a maximum morphine dose of 40 mg per 24 hours.
|
24 hours
|
Hemodynamics
Time Frame: duration of operation up to 6 hours
|
Intraoperative MAP and HR were measured after the skin incision, and then every 30 minutes until the end of surgery.
|
duration of operation up to 6 hours
|
opioid consumption.
Time Frame: duration of operation up to 6 hours
|
Intraoperative opioid (fentanyl) consumption.The failed block was considered when ≥ four additional doses of fentanyl were required to manage the increased MAP or HR after skin incision.
|
duration of operation up to 6 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MS-425-2023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia
-
Samsun UniversityCompletedAnesthesia | Regional Anesthesia | Anesthesia ManagementTurkey
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
Aligarh Muslim UniversityCompletedAnesthesia | Anesthesia Intubation Complication | Anesthesia; Adverse EffectIndia
-
University of ChicagoRecruitingAnesthesia | Patient Satisfaction | Anesthesia Risks | Anesthesia Consent | Consent RetentionUnited States
-
Universitas Sebelas MaretIndonesia Endowment Fund for EducationNot yet recruitingAnesthesia | Anesthesia; Reaction
-
University of PecsCompleted
-
Hormozgan University of Medical SciencesUnknownAnesthesia | Anesthesia; FunctionalIran, Islamic Republic of
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMRecruitingPrediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population (CME)Anesthesia, Local | AnesthesiaFrance
-
Matthew BorzageRecruitingAnesthesia | Anesthesia; ReactionUnited States
Clinical Trials on Cervical Plexus Block
-
Istanbul UniversityCompleted
-
Cangzhou Hospital of Integrated Traditional Chinese...Completed
-
Mahidol UniversityCompletedThyroid Nodule | Parathyroid AdenomaThailand
-
Cangzhou Hospital of Integrated Traditional Chinese...Completed
-
Beijing Tiantan HospitalCompleted
-
Cleveland Clinic Akron GeneralRecruitingPain | Superficial Cervical Plexus BlockUnited States
-
Beijing Tiantan HospitalRecruitingPlexus Block;Analgesia;NeurosurgeryChina
-
University of PennsylvaniaAbiomed Inc.Not yet recruiting
-
San Salvatore Hospital of L'AquilaCompletedNeuropathic Pain | Somatic PainItaly
-
Zagazig UniversityCompleted